University of Maryland School of Medicine names Pittsburgh medical professor as new dean – Baltimore Sun

Dr. Mark T. Gladwin was named as the subsequent dean of the University of Maryland School of Medicine after a nationwide search to interchange Dr. E. Albert Reece, who introduced final yr he would step down after 16 years of main the medical faculty.

Gladwin is a coronary heart, vascular and lung doctor and scientist, and at present serves as a professor and chair of the division of drugs on the University of Pittsburgh School of Medicine.

He will start the brand new positions of dean and vice chairman for medical affairs August 1 at a time when the Baltimore medical faculty has vastly elevated its analysis and scientific {dollars} and its footprint. He will earn about $1 million a yr in wage as dean, in accordance with the college.

Research funding reached $600 million lately and scientific revenues at the moment are round $350 million, with school physicians offering inpatient and outpatient care to greater than 1.5 million sufferers yearly at 62 areas round Maryland. The faculty additionally maintains analysis and therapy services in 30 nations.

It holds 130 U.S. and 228 overseas patents and 205 know-how licenses and its school have made 576 scientific disclosure and began 33 corporations.

The Maryland medical faculty turned identified throughout the coronavirus pandemic for creating and testing therapies and vaccines. And in January it gained consideration for performing the primary transplant of a genetically modified pig coronary heart right into a affected person, who lived for 2 months after the surgical procedure.

“I am very honored to have been selected as dean of one of the most prestigious medical schools in the country,” Gladwin stated in a press release.

“Everything I learned during my visit to UMB furthered my desire to join the University of Maryland School of Medicine,” he stated. “I was already well aware of its reputation for excellence in education, research, clinical care and community outreach. I look forward to listening to, and learning from UMB faculty, staff, and students as we continue the crucial work of carrying the School’s mission forward in Baltimore, around the state and around the world.”

Gladwin comes with an in depth scientific, administration and analysis resume.

He additionally serves as affiliate dean for physician-scientist mentoring and affiliate vice chancellor for science technique, well being sciences, on the University of Pittsburgh School of Medicine. He was a founding father of the Pittsburgh Heart, Lung, Blood and Vascular Medicine Institute.

“I could not be more pleased to announce Dr. Gladwin as the next dean of the University of Maryland School of Medicine,” stated Dr. Bruce E. Jarrell, president of the University of Maryland, Baltimore, who introduced the appointment in a letter Tuesday to college, employees and college students. “I am confident he will continue to enrich the legacy of our School of Medicine and position our world-class institution to meet the challenges of the future.”

Officials stated they sought a brand new chief who may oversee tutorial and scientific missions, work with the encompassing Baltimore neighborhood and preserve the partnership with the University of Maryland Medical System, the affiliated 13-hospital community within the state.

Search committee members known as the job difficult and multifaceted and stated Gladwin had the proper {qualifications}.

“The search committee was impressed by not only his experience, but also his vision for the future of medicine and the role of the medical school in today’s society,” stated Claire M. Fraser, a professor of drugs and director of the Institute for Genome Sciences and chair of the search committee.

Aishwarya Iyer, an MD/PhD scholar within the School of Medicine and president of the University Student Government Association additionally was on the choice committee.

“I thought his research portfolio was phenomenal,” she stated. “He comes from a really strong institution and has a lot of experience managing his position very well and very efficiently. I am excited to welcome this new dean.”

Selection committee members stated Gladwin additionally would be capable to fulfill one other want of the job, guaranteeing range, fairness and inclusion.

In Pittsburgh, he created a brand new vice chair place for range and inclusion and labored with the residency director to develop a specialty observe geared toward attracting underrepresented minorities, amongst different initiatives.

The Morning Sun

The Morning Sun


Get your morning information in your e-mail inbox. Get all the highest information and sports activities from the

That work will proceed at Maryland, the place the medical faculty already has undergone adjustments to deal with allegations of sexual harassment and of a failure to create an equitable surroundings for girls. In response in 2018, the college took a number of steps beneath a program known as Program in Cultural Transformation that included selling a number of ladies to govt management positions and making a committee to make extra suggestions and assess progress.

Gladwin earned his bachelor’s and medical levels from the University of Miami and accomplished his internship and chief residency in inside drugs on the Oregon Health Science University. He accomplished a essential care drugs fellowship on the National Institutes of Health and a pulmonary fellowship on the University of Washington in Seattle.

He has served in varied positions at NIH and the University of Pittsburgh, the place he was recruited in 2008 to function chief of the division of pulmonary, allergy and demanding care drugs and the inaugural director of the Vascular Medicine Institute. He turned division chair in 2014 and oversaw 800 school and $300 million in scientific and analysis funding.

Sickle cell analysis has been a particular focus for Gladwin for greater than 20 years. He has a whole bunch of revealed manuscripts within the fields of vascular and nitric oxide biology and has been the principal investigator on main scientific trials.

He was born in Palo Alto, California, and raised across the nation and in Ghana, Mexico and Guatemala.

Dean Reece will stay as a part of the medical faculty’s school and as director of a brand new Center for Advanced Research, Training and Innovation and as co-director the college’s Center for Birth Defects Research.

“On behalf of the School of Medicine, I’m delighted to extend heartiest congratulations and a warm welcome to Dr Gladwin on his decanal appointment,” Reece stated in a press release. “I’m most pleased to ‘pass the baton’ to him and look forward to his leadership in the years to come.”

Source hyperlink

Leave a Reply

Your email address will not be published.